Avidity Partners Management LP Sells 8,400 Shares of HealthEquity, Inc. $HQY

Avidity Partners Management LP reduced its stake in HealthEquity, Inc. (NASDAQ:HQY) by 33.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 16,900 shares of the company’s stock after selling 8,400 shares during the quarter. Avidity Partners Management LP’s holdings in HealthEquity were worth $1,548,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of HQY. William Blair Investment Management LLC bought a new stake in HealthEquity in the 4th quarter valued at $169,956,000. Norges Bank bought a new stake in shares of HealthEquity in the 4th quarter worth about $66,927,000. AQR Capital Management LLC increased its holdings in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of HealthEquity by 229,985.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock worth $43,843,000 after buying an additional 478,370 shares during the last quarter. Finally, Westfield Capital Management Co. LP increased its holdings in shares of HealthEquity by 35.7% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after buying an additional 451,450 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HQY shares. JPMorgan Chase & Co. reduced their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. Barclays reduced their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Raymond James Financial set a $100.00 target price on shares of HealthEquity in a report on Tuesday, February 17th. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Finally, KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Price Performance

HQY stock opened at $88.34 on Friday. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $106.60. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $84.64 and a 200 day moving average price of $85.87. The stock has a market cap of $7.39 billion, a PE ratio of 33.09, a P/E/G ratio of 1.49 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 13,081 shares of company stock valued at $1,193,000. Company insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.